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Background: Chronic cough patients are rendered therapies for gastro-esophageal reflux (GERD), upper airway
cough syndrome (UACS) and cough-variant asthma (CVA) with varying benefit. Idiopathic or unexplained cough
has emerged as an important clinical entity in both primary care and subspecialty clinics. Recent evidence points to
a link between chronic cough and untreated obstructive sleep apnea (OSA).
Methods: A prospective observational study was done to evaluate the effect of OSA therapy in patients with
chronic cough. Patients enrolled into the study underwent questionnaires to evaluate for GERD, UACS and CVA
along with screening questionnaires for OSA and daytime sleepiness. The Leicester cough questionnaire (LCQ) was
done at baseline and during serial visits to evaluate cough intensity and was used as the primary outcome measure
of the effect of CPAP therapy on chronic cough.
Results: Out of 37 patients enrolled into the study, only 28 patients had follow up LCQ scores available and
therefore underwent analysis. 22/28 patients were suspected to have OSA based on abnormal STOP-BANG
screening questionnaire scores and overnight oximetry abnormalities. Of these 19/28 patients had overnight
attended polysomnography with definitive diagnosis of OSA yielding a 68% prevalence of OSA in our chronic
cough population. Chronic cough patients treated for OSA tended to be older with a significantly higher BMI than
chronic cough patients without OSA. Significant improvement of LCQ scores occurred with CPAP therapy for OSA
in chronic cough patients.
Conclusion: OSA is significantly prevalent in chronic cough patients. Subjects with chronic cough and OSA tend to
be older and obese. Treatment of OSA in chronic cough patients yields significant improvement in their health
status.
Keywords: Cough, Sleep apnea, Obstructive, Continuous positive airway pressureBackground
Chronic cough is an important health-care problem in
both primary care and subspecialty clinics [1]. The 2006
ACCP guidelines emphasize the need to aggressively
address the etiologies of gastro-esophageal reflux disease
(GERD), upper airway cough syndrome (UACS) and
cough-variant asthma (CVA) while treating patients with
chronic cough [2]. Despite undertaking prolonged courses
of therapies directed at GERD, UACS and CVA, a signifi-
cant proportion of patients continue to experience
persisting cough [3]. The percentage of chronic unrelen-* Correspondence: krishna.sundar@hsc.utah.edu
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reproduction in any medium, provided the orting cough termed as “unexplained” or “idiopathic cough”
has ranged up to 42% in different studies [4].
Newer approaches at dissecting the etiology of unex-
plained cough have focused upon the role of ongoing
non-acid reflux [5], under-recognized vocal cord dys-
function [6] and untreated obstructive sleep apnea
(OSA) [7] in perpetuating chronic cough. A large retro-
spective study from our clinic population during the
period 2006–2009 revealed that 44% of the 75 patients
with chronic cough had underlying OSA [8]. More im-
portantly, therapy for comorbid OSA with continuous
positive airway pressure (CPAP) resulted in improve-
ment or resolution of cough in 93% of the patients [8].
While the prevalence of OSA in this large retrospective
analysis was felt to be quite high, it was still consideredLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Sundar et al. Cough 2013, 9:19 Page 2 of 7
http://www.coughjournal.com/content/9/1/19to be an underestimate as all patients were not systemat-
ically screened for OSA [8]. Additionally, while a role for
treatment of OSA was implicated in the resolution of
cough, all patients received concurrent therapy for
GERD, UACS or CVA that may have contributed to the
resolution of chronic cough in this study [8].
The aim of the current study was to prospectively inves-
tigate the impact of CPAP therapy on predefined-cough
measures in patients with OSA associated chronic cough.
Patients referred primarily for chronic cough were evalu-
ated for OSA using validated questionnaires and objective
testing for OSA; the effect of CPAP on those diagnosed
definitively with comorbid OSA was serially assessed. The
primary outcome was the effect of CPAP therapy on the
total Leicester cough questionnaire score.Methods
All consecutive patients with chronic cough seen at
Intermountain Utah Valley Pulmonary Clinic, Provo,
Utah were given the option to enroll into this study
between March 2010- February 2012. Inclusion criteria
included the following:
– Cough more than 2 months duration
– Normal spirometry and diffusion capacity <70% of
predicted
– Normal chest radiographs and/or CT scans of the
chest
– Age >18 years
Exclusion criteria included:
– History of lung disease in the form of prior
diagnoses of asthma, COPD, interstitial lung disease
or sarcoidosis.
– Chronic disease states such as congestive heart
failure, chronic kidney disease, cancer, need for
immunosuppressive therapy, or any debilitating
illness that prevented follow up.
– Any history of smoking or history of being in
occupations that resulted in inhalational exposures.
– Pregnancy.
– Use of opiate containing cough suppressants and/or
first-generation antihistaminics.
Based on the above inclusion–exclusion criteria, 37
consecutive patients with chronic cough were enrolled
over a 2-year period. A total of 46 patients were found
eligible for the study but 9 patients either did not con-
sent for the study, were on cough suppressants that
made them ineligible, or turned out to have other diag-
noses on follow-up (e.g. one patient had mediastinal
adenopathy on chest CT). After enrolment, patientsundertook the following questionnaires at baseline and
on follow up –
1. Assessments for cough severity using the Leicester
cough questionnaire (LCQ). LCQ is a validated,
well-studied 19-point questionnaire that assesses the
impact of cough severity on multiple aspects of daily
living [9]. Amongst available cough questionnaires,
LCQ has been shown to correlate the most with
objective cough frequency as assessed by cough
monitors [10]. In the current study, subjects
underwent LCQ assessments at baseline and during
each follow up visit.
2. Screening for OSA was done at baseline visit using
the STOP-BANG questionnaire. Amongst available
screening tools for OSA, the 8-point STOP-BANG
questionnaire has emerged as one of the most easy
to use [11]. While the sensitivity for a STOP-BANG
score of 3 or more for detecting OSA (apnea-
hypopnea index (AHI)>5/hour) is 83.6-85.1%, using
a STOP-BANG score of 3 or more is not entirely
reliable for excluding mild OSA [12]. Workup for
further diagnosis of OSA was left up to the treating
physician. Further evaluation for OSA was based
upon a STOP-BANG score of ≥3 along with results
of Epworth Sleepiness Score (ESS), and the finding
of other symptoms relating to sleep-disordered
breathing and daytime dysfunction. Many patients
underwent screening oximetry before they were
subjected to a polysomnography (PSG) for definitive
diagnosis of OSA. Based upon the results of PSG,
the OSA severity was categorized based upon the
apnea-hypopnea index -AHI. Since the workup for
OSA was left up to the treating physician, there was
a potential for underestimation of the prevalence of
OSA in chronic cough patients since all of these
patients were not subjected to the gold-standard for
diagnosing OSA – attended PSG. Attended PSG was
done at an accredited sleep laboratory (Utah Sleep
Disorders Center, Provo, Utah) and studies were
performed according to American Academy of Sleep
Medicine Criteria. The recording montage included
EEG leads C4-M1, C3-M2, Cz-Oz, Cz-Fz,
bilateral electrooculogram, chin EMG,
electrocardiogram, a microphone for recording
snoring, monitors of airflow, chest and abdominal
effort recordings, oximetry, and if applied, the
level of CPAP mask flow and leak. Sleep stage
scoring was performed according to AASM
criteria. Apnea was defined as a decrease to ≤10%
of baseline of thermistor airflow signal and a
hypopnea was defined as a 30% or greater
decrease in airflow signal accompanied by a 4%
oximetric desaturation or an arousal.
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UACS and CVA at baseline. This was done using
validated questionnaires for each of these
commonly-treated chronic cough etiologies using
the GERD [13], SNOT-20 [14], and asthma life
questionnaires [15]. Each of these questionnaires is
used for screening and for following the severity of
symptoms of GERD, UACS and asthma over time
[13-15]. Usage of these validated questionnaires was
felt to be necessary as clinician-driven assessments
of GERD, UACS and CVA in chronic cough patients
tend to be subjective with insufficient
documentation regarding symptomatology of these
problems in chronic cough patients. The GERD
questionnaire comprised of 4 questions relating to
symptoms of GERD (or their control) with grading
of intensity of these symptom intensity from 0–3
(score range 0–12 [13]). The SNOT-20 involved
responses to 20 questions with a symptom response
score of 0–5 (score range 0–100) [14] and the
asthma life questionnaire has 20 questions with a yes
or no response (score range 0–20) [15].
Following baseline assessments, additional workup and
management of OSA was left up to the treating pulmo-
nologist. Since patients were often on therapies for
UACS, GERD and CVA at the time of initial evaluation,
the need for continuation of these therapies was left up
to the treating physician. While it was recommended
that newer therapies for GERD, UACS or CVA would
not be started unless felt absolutely necessary, in order
to ensure patient comfort, treating physicians were
allowed to start additional treatments for GERD, CVA
and UACS if felt absolutely essential. The use of cough-
suppressants such as first-generation antihistaminics and
opiates was disallowed due to the possibility that these
treatments would confound effects on chronic cough
from OSA therapy. Therefore patients receiving these
therapies were excluded from the study.
Follow up after initial baseline visit was done at the
discretion of the treating physician. Patients non-
compliant with CPAP therapy or PSG recommendations
were continued till the end of the study if they contin-
ued to complete their LCQs during follow up visits. The
study and approval for publication without disclosure of
identifying data was obtained from the Intermountain
Institutional Review Board, Intermountain Healthcare,
Salt Lake City, Utah.
Results
Out of a total of 37 patients with chronic cough that
were initially enrolled into the study between 2010–
2012, 19 patients with chronic cough and objectively
verified OSA were followed and showed significantimprovement in LCQ scores following CPAP interven-
tion. 9/37 patients enrolled were excluded due to non-
compliance with follow up. Out of the 28 patients that
completed follow-up LCQ questionnaires, 22 patients
reported a STOP-BANG score of 3 or more leading to
further evaluations for OSA (Figure 1). In these 22 pa-
tients, 13 oximetries were carried out all of which were
abnormal. Out of these 22 patients, 3 patients were non-
compliant with recommendations for further OSA
evaluation but continued to follow-up on therapies for
GERD (3/3) and UACS (1/3) (Figure 1). 19/28 patients
had objective polysomnographic evidence of OSA. Out
of these 19 patients, 2 patients had previously known
OSA but were noncompliant with therapy and were
optimized on CPAP based on prior polysomnographic
data; 17 patients underwent PSGs following enrolment
into the study. Of the 17 patients that were studied with
PSG following enrolment into study, the mean AHI was
35.3±29.5 with 6/17 patients being in the mild OSA cat-
egory (AHI 5-15/hr), 4/17 patients in the moderate OSA
category (AHI 15-30/hr) and 7/17 patients being in the
severe OSA category (AHI>30/hr).
15/19 patients that were treated with CPAP were on
proton-pump inhibitors for GERD, 11/19 were on
therapy for UACS and 7 were on treatment for CVA
(Figure 2a). No ACE-inhibitor use was noted in this
population. As reflected in the questionnaires obtained
at time of enrolment for this study, mean symptom
scores for GERD, UACS and asthma were low for the
enrolled chronic cough subjects.
Table 1 details the clinical characteristics of the groups
of patients followed in this study. Patients that were
treated for OSA with CPAP were tended to be older,
significantly heavier with higher STOP-BANG OSA
screening scores. Although they tended to have longer
durations of cough as compared to those diagnosed
without OSA, there was no significant difference in
durations of cough between patients with and without
OSA (Table 1). The six patients that did not undergo
further evaluation for OSA based on STOP-BANG
scores and clinical evaluation comprised a small com-
parison group for the group of 19 patients that were
treated with CPAP (Table 1). Interestingly, there was no
significant difference in the mean scores on the GERD,
SNOT-20 and ALQ questionnaires (Table 1) between
the OSA and non-OSA groups although there were dif-
ferences in cough therapies rendered for these two
groups (Figure 2b).
Table 2 shows changes in total LCQ scores for the
CPAP-treated group of chronic cough patients with
breakdown of LCQ scores into different domains. In
patients treated with CPAP, there was a significant
improvement in total LCQ scores, and LCQ scores in
psychological and social domains (Table 2 & Figure 3).
37 patients enrolled into the study 2010-2011
54.6±14.4 years
26F: 12 M
Overall BMI 31.7± 6.9 
Female (BMI) 32.6 ± 8.1 
Male (BMI) 30 ± 3.7 
Mean cough duration 
37.8 ± 89.6 months 
28 patients had follow up LCQ scores 2 or more times (9 patients excluded)
57.3 ± 14.8 years
20F:8M
Overall BMI 32.1±16.8
Female (BMI) 32.9±7.5
Male (BMI) 30.2±4.5 
Mean cough duration
29.6 ± 34.3 months 
22/28 patients with STOP-BANG scores of 3 or more
19/22 patients diagnosed to have OSA based on PSG (3 patients refused further PSG despite abnormal 
nocturnal oximetry).
Figure 1 Flowchart detailing enrolment and follow up in the study.
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The current emphasis on finding mechanistic bases of
cough have led to the recognition that chronic cough is
a multi-trigger driven process that is not amenable to a
single therapeutic intervention [16,17]. A disease with a
potential to affect number of processes within the upper
and lower airways is OSA [18]. In order to understand
the effects from an intervention on chronic cough, stud-
ies in the last decade have typically used validated cough
questionnaires, cough sensitivity assessments or object-
ive cough monitoring to assess cough serially [19].
Amongst these, serial LCQ measurement of total and in-
dividual domain scores in chronic cough subjects is the
most-validated and widely utilized instrument to assess0
2
4
6
8
10
12
GERD
only
UACS
only
CVA
only
GERD
and
UACS
GERD
and
CVA
Cough Etiologies in a b
Patients with OSA
(n=22)
0
0.5
1
1.5
2
2.5
Figure 2 (A & B) Etiologies of cough in patients with OSA and withoueffects from an intervention [19] and a change in LCQ
score(s) was used to assess the effect of CPAP therapy in
chronic cough patients with co-morbid OSA.
Based on the results of the STOP-BANG screening
questionnaire and the more definitive gold standard of
attended PSG, this study shows a high prevalence of ob-
structive sleep apnea in chronic cough patients. Reasons
for the high prevalence of OSA noted in this study are
manifold. OSA is a commonly-encountered disorder that
has reached epidemic proportions [20]. Screening ques-
tionnaires while useful in directing the need for further
testing however are not 100% sensitive for detecting
milder forms of disease. Therefore while these question-
naires are useful for elaborating the need for furtherGERD only CVA only GERD and CVA
Cough Etiologies in 
Patients without OSA  
(n=6)
t OSA.
Table 1 Results of baseline questionnaires between
CPAP-treated and non-treated groups
Patients treated
with CPAP (n=19)
Patients treated
without CPAP (n=6) P value
Age (years) 58.7±15.1 44.7±13 0.05
Sex ratio 13 F:6 M 5 F:1 M NA
BMI 34.9±6.7 26.5±4 0.002
Cough
duration
(months)
33.8±38.1 15.5±12.2 0.08
SNOT-20 score 8.8±4.2 5.5±3.1 0.8
GERD score 1.8±1.3 1±1.3 0.2
Asthma life
questionnaire
38.8±20.5 36.3±19.3 0.07
STOP-BANG
score
4.3±1.7 1.5±2.7 0.009
0-2 1/19 4/6
3-5 14/19 2/6
5-8 4/19 0/6
Epworth
Sleepiness
score
11.25±4.2 4±4.8 0.01
Abbreviations: CPAP Continuous positive airway pressure, BMI Body mass
index, SNOT Sino-nasal outcome test, GERD Gastroesophageal reflux disease.
0
5
10
15
20
25
Pre CPAP Post CPAP
LC
Q 
To
ta
l S
co
re
N = 19
p value = .002 
Figure 3 Change in LCQ total score with CPAP therapy.
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their results have to be used in conjunction with other
diagnostic modalities for OSA [12]. In our study, while
we used a cut-off of a score of 3 or more on the STOP-
BANG score as a way of directing need for further
testing of OSA, not all physicians used this solely for
ordering further polysomnographic testing. Increasing
STOP-BANG scores are correlated with higher likeli-
hood for OSA and all patients with scores of 5 or more
were tested for OSA and all these patients were found to
have significant OSA on PSG. 1/19 patients in the OSA
group had STOP-BANG scores of less than 3 and 2/6
patients in the non-OSA group had STOP-BANG scores
of 3–4. There was also wide variation in the ESS scores
in OSA vs. non-OSA groups although OSA patients hadTable 2 Leicester cough questionnaire scores change in
CPAP-treated chronic cough patients
CPAP treated patients (n=19)
LCQ domains Baseline Final P value
Physical 4.6±1.2 5.2±1.1 0.086
Pyschologic 4.1±1.4 5.3±1.2 0.005
Social 3.8±1.7 5.5±1.6 0.003
LCQ Total 12.5±4 16.6±3.9 0.002
Duration of follow up (days) 157.3±108.5
Abbreviations: CPAP Continuous positive airway pressure, LCQ Leicester
cough questionnaire.a significantly increased ESS than the non-OSA group
(Table 1).
The gold standard for OSA diagnosis remains the
attended PSG. In our study 22/28 patients were felt to
have a high likelihood of OSA based the combination of
abnormal STOP-BANG scores and overnight oximetries
yielding an OSA prevalence of 78% in chronic cough
patients. Based on definitive PSGs, 19/28 patients had
OSA yielding a prevalence of 68% OSA in this chronic
cough population. This high prevalence of OSA in our
chronic cough population may have been from higher
BMIs of the patient population in this study [8]. This
finding of increased BMIs in our population contrasts
with the average BMI reported by recent studies on
chronic cough from Europe [5,21]. Aside from a signifi-
cant difference in BMIs in OSA and non-OSA groups,
there was also a trend towards a lower age in chronic
cough patients without OSA. Chronic cough patients
without OSA tended to be younger with a higher female
preponderance. These findings are in congruence with
the results of studies that have shown a correlation be-
tween OSA prevalence and age [22], OSA and male sex
[22], and OSA and BMI [23].
A number of questionnaires were administered in this
study that assessed symptom intensity scores for com-
monly encountered entities of GERD, UACS and CVA.
While the scores from these questionnaires do not ac-
curately assess the severity of the individual disorders of
GERD, UACS and CVA, this was undertaken in order to
compare the OSA and non-OSA groups in terms of the
prevalence for symptoms of these three commonly en-
countered disorders. While the therapies for GERD,
UACS and to some extent even CVA is somewhat em-
piric in most chronic cough patients, a greater problem
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ning to these three conditions in a consistent manner by
physicians. Therefore instead of trying to decipher under-
lying cough etiologies based upon treatments rendered
and clinic records, we decided to use these validated ques-
tionnaires to develop scores for GERD, UACS and CVA.
This approach to categorize and evaluate these three
conditions in diagnostic and testing protocols has been
used to direct comprehensive therapy for chronic cough
patients [24,25] although given the high prevalence of
these conditions in the general population, their relation
to patient’s cough is unclear [26] . In this study as well,
there appeared to be a preponderance of therapies ren-
dered for GERD as well as therapies for multiple etiologies
for cough as was noted in our retrospective study [8].
Even though patients with chronic cough and OSA tended
to be older and significantly heavier, there was no differ-
ence in patient reported scores for UACS, GERD and
CVA between OSA and non-OSA subjects..
In the subjects treated with CPAP, there was a signifi-
cant improvement in LCQ scores in chronic cough sub-
jects with OSA. This occurred in both the total LCQ
scores and the individual psychological and social do-
mains. This supports prior observations that CPAP
therapy for comorbid OSA improves cough outcomes
in this population [8]. LCQ change is an established
method for measuring efficacy of interventions on
cough [27-29] and not all studies have included a pla-
cebo arm while assessing efficacy of an intervention
on LCQ improvement [30]. In these chronic cough
studies, the mean LCQ change with intervention
have ranged from 2.1- 3.5 and with placebo 1.1-2.6
[27-29]. One of the problems with our study was that
even though a significant change was not expected in
the LCQ score of those patients that were not treated
with CPAP for OSA, the three non-compliant patients
in the study also showed an increase in LCQ scores.
This underscores the need for studying the effect of
CPAP on cough intensity in chronic cough patients
using a placebo arm.
Recently the observation that CPAP therapy can im-
prove cough in patients with concomitant OSA has been
reported by others [31,32]. In one case report, an im-
provement in Ryan score (a measure of pharyngeal pH
done through a transnasal probe) occurred following
CPAP therapy accompanied by improvement in cough
intensity and sensitivity [31]. Further studies need to not
only clarify cough populations that improve following
CPAP therapy but also the mechanistic bases of cough
improvement after CPAP therapy. Studies using a
placebo arm (sham CPAP controls) are needed to under-
stand fully the benefit accorded by CPAP therapy on
cough intensity and sensitivity in patients with chronic
cough.Conclusion
There is a high prevalence of OSA in patients with
chronic cough. Patients with chronic cough and OSA
tend to be older and significantly heavier. Significant im-
provement in health status occurs following CPAP ther-
apy occurs in chronic cough patients with OSA. Further
studies trying to demonstrate a role for CPAP therapy
should include a placebo arm (or sham CPAP) for con-
clusively establishing a benefit of CPAP therapy on
chronic cough. The mechanisms for cough improvement
from CPAP therapy can multiple and future studies
should also attempt to understand the pathways involved
in cough improvement with CPAP therapy.
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